Enhanced renoprotective effect of HIF-1α modified human adipose-derived stem cells on cisplatin-induced acute kidney injury in vivo

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Wei Wei ^a   Li, Ze Zheng ^a   Wang, Wei ^a   Jiang, Yan ^a   Cheng, Jin ^a   Lu, Shi ^a   Zhang, Jin Yuan ^a  

^a Jimin Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AUTACOID; CISPLATIN; CYTOKINE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ACUTE KIDNEY INJURY; ADIPOSE TISSUE; ANIMAL; APOPTOSIS; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; TRANSPLANTATION;

ACUTE KIDNEY INJURY; ADIPOSE TISSUE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDUCED PLURIPOTENT STEM CELLS; INFLAMMATION MEDIATORS; KIDNEY FUNCTION TESTS;

EID: 84930632758     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10851     Document Type: Article

References (28)

1. Chawla, L. S., Eggers, P. W., Star, R. A. & Kimmel, P. L. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371, 58-66 (2014).
2. Ekor, M., Emerole, G. O. & Farombi, E. O. Phenolic extract of soybean (Glycine max) attenuates cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol 48, 1005-12 (2010).
3. Lattanzio, M. R. & Kopyt, N. P. Acute kidney injury: new concepts in definition, diagnosis, pathophysiology, and treatment. J Am Osteopath Assoc 109, 13-9 (2009).
4. Rondon-Berrios, H. & Palevsky, P. M. Treatment of acute kidney injury: an update on the management of renal replacement therapy. Curr Opin Nephrol Hypertens 16, 64-70 (2007).
5. Yeagy, B. A. et al. Kidney preservation by bone marrow cell transplantation in hereditary nephropathy. Kidney Int 79, 1198-206 (2011).
6. Wan, J. X., Zou, Z. H., You, D. Y., Cui, J. & Pan, Y. B. Bone marrow-derived mesenchymal stem cells differentiation into tubular epithelial-like cells in vitro. Cell Biochem Funct 30, 129-38 (2012).
7. Zuk, P. A. et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211-28 (2001).
8. Sun, X. & Wei, Y. The role of hypoxia-inducible factor in osteogenesis and chondrogenesis. Cytotherapy 11, 261-7 (2009).
9. Zhao, Y. et al. Neurogenic differentiation from adipose-derived stem cells and application for autologous transplantation in spinal cord injury. Cell Tissue Bank (2014).
10. Shi, Z., Neoh, K. G., Kang, E. T., Poh, C. K. & Wang, W. Enhanced endothelial differentiation of adipose-derived stem cells by substrate nanotopography. J Tissue Eng Regen Med 8, 50-8 (2014).
11. Zhu, X. S., He, B. X., Zhou, X. N. & Ren, J. Comparison of the effects of human adipose and bone marrow mesenchymal stem cells on T lymphocytes. Cell Biol Int 1, 11-8 (2013).
12. Hill, P. et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 19, 39-46 (2008).
13. Elson, D. A. et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxiainducible factor-1alpha. Genes Dev 15, 2520-32 (2001).
14. Kapitsinou, P. P. et al. Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury. Am J Physiol Renal Physiol 302, F1172-9 (2012).
15. Schodel, J. et al. HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am J Pathol 174, 1663-74 (2009).
16. Wang, W. & Zhang, J. Induction of renoprotective gene expression by hypoxia-inducible transcription factor-1alpha ameliorates renal damage. Med Hypotheses 70, 948-50 (2008).
17. Tanaka, T. et al. Induction of protective genes by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis. Kidney Int 68, 2714-25 (2005).
18. Jiang, Y. B. et al. [Effects of autologous mesenchymal stem cells transfected with heme oxygenase-1 gene transplantation on ischemic Swine hearts]. Zhonghua Xin Xue Guan Bing Za Zhi 37, 692-5 (2009).
19. Wang, W. W. et al. Human adipose-derived stem cells modified by HIF-1a accelerate the recovery of cisplatin-induced acute renal injury in vitro. Biotechnol Lett 36, 667-76 (2014).
20. Kim, J. H. et al. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 302, F1141-50 (2012).
21. Akcay, A., Nguyen, Q. & Edelstein, C. L. Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009, 137072 (2009).
22. Jia, Z. et al. Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis. Kidney Int 79, 77-88 (2011).
23. Kang, K. P. et al. Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant 24, 3012-20 (2009).
24. Ramesh, G. & Reeves, W. B. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110, 835-42 (2002).
25. Tsubokawa, T. et al. Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia. Am J Physiol Heart Circ Physiol 298, H1320-9 (2010).
26. Zeng, B. et al. Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement. Cell Biol Int 32, 1256-64 (2008).
27. Zarjou, A. et al. Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. Am J Physiol Renal Physiol 300, F254-62 (2011).
28. Haq, M., Norman, J., Saba, S. R., Ramirez, G. & Rabb, H. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 9, 614-9 (1998).